Prot# 104532: Pilot Neoadjuvant Trial in Breast Cancer with Combination of ABI-007 (Abraxane) and GW572016 (Lapatinib) (NU Prot# NU 05B2)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/29/05 → 7/1/19

Funding

  • GlaxoSmithKline plc (104532 / NU 05B2)